Laporan Laba Rugi 524404 - TTM - Marksans Pharma Limited

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Marksans Pharma Limited menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

	2020 09-30	2020 12-31	2021 03-31	2021 06-30	2021 09-30	2021 12-31	2022 03-31	2022 06-30	2022 09-30	2022 12-31	2023 03-31	2023 06-30	2023 09-30	2023 12-31	2024 03-31	2024 06-30	2024 09-30	2024 12-31	2025 03-31	2025 06-30
Revenue	13,142	13,817	13,762	14,064	14,026	14,069	14,908	15,756	16,670	17,842	18,521	19,184	19,971	21,034	21,774	22,680	23,787	24,744	26,228	26,522
Change (%)		5.14	-0.40	2.19	-0.27	0.30	5.97	5.69	5.80	7.03	3.81	3.58	4.10	5.32	3.52	4.16	4.88	4.02	6.00	1.12
% of Revenue	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00

Cost Of Sales	5,995	6,008	6,056	6,178	6,400	6,661	7,295	7,821	8,299	9,019	9,401	9,680	9,975	10,309	10,740	10,571	10,940	11,195	11,981	11,981
Change (%)		0.22	0.79	2.02	3.59	4.08	9.53	7.20	6.12	8.67	4.24	2.97	3.05	3.34	4.19	-1.57	3.49	2.33	7.02	0.00
% of Revenue	45.62	43.48	44.00	43.93	45.63	47.34	48.94	49.64	49.78	50.55	50.76	50.46	49.95	49.01	49.33	46.61	45.99	45.24	45.68	45.18

Gross Operating Profit	7,147	7,809	7,706	7,886	7,626	7,408	7,613	7,936	8,371	8,823	9,120	9,504	9,995	10,725	11,034	12,108	12,847	13,549	14,247	14,541
Change (%)		9.27	-1.32	2.33	-3.29	-2.86	2.76	4.24	5.49	5.40	3.37	4.20	5.17	7.30	2.88	9.74	6.10	5.46	5.16	2.06
% of Revenue	54.38	56.52	56.00	56.07	54.37	52.66	51.06	50.36	50.22	49.45	49.24	49.54	50.05	50.99	50.67	53.39	54.01	54.76	54.32	54.82

SG&A	1,833	1,908	2,096	2,037	2,269	2,351	2,250	2,326	2,375	2,436	2,523	2,637	2,752	2,875	3,059	3,059	3,312	3,451	3,620	3,799
Change (%)		4.04	9.90	-2.85	11.40	3.63	-4.29	3.37	2.10	2.56	3.57	4.52	4.34	4.48	6.40	0.00	8.26	4.20	4.91	4.94
% of Revenue	13.95	13.81	15.23	14.48	16.18	16.71	15.10	14.76	14.25	13.65	13.62	13.75	13.78	13.67	14.05	13.49	13.92	13.95	13.80	14.32

R&D
Change (%)
% of Revenue

OpEx	10,797	11,078	10,670	10,834	10,939	11,314	12,767	13,697	14,475	15,501	15,644	16,041	16,526	17,118	17,931	18,640	19,549	20,436	21,776	22,380
Change (%)		2.61	-3.69	1.54	0.96	3.43	12.85	7.28	5.68	7.08	0.93	2.54	3.02	3.58	4.75	3.95	4.88	4.54	6.56	2.77
% of Revenue	82.15	80.18	77.53	77.04	77.99	80.42	85.64	86.93	86.83	86.88	84.46	83.62	82.75	81.38	82.35	82.19	82.18	82.59	83.03	84.38

Operating Income	2,345	2,739	3,092	3,229	3,087	2,755	2,141	2,060	2,195	2,341	2,877	3,143	3,445	3,916	3,843	4,040	4,238	4,308	4,452	4,142
Change (%)		16.77	12.91	4.44	-4.40	-10.77	-22.29	-3.79	6.55	6.68	22.89	9.23	9.60	13.68	-1.86	5.12	4.89	1.67	3.34	-6.96
% of Revenue	17.85	19.82	22.47	22.96	22.01	19.58	14.36	13.07	13.17	13.12	15.54	16.38	17.25	18.62	17.65	17.81	17.82	17.41	16.97	15.62

Interest Expense	-42	-43	-38	-74	-28	-21	-57	-66	-76	-90	-61	-59	-50	-58	-112	-126	-136	-131	-117	-148
Change (%)		0.59	-10.42	93.92	-62.16	-25.82	176.27	14.53	15.74	18.41	-32.34	-3.67	-15.50	16.28	94.16	12.03	8.03	-3.64	-10.76	26.94
% of Revenue	-0.32	-0.31	-0.28	-0.53	-0.20	-0.15	-0.39	-0.42	-0.46	-0.50	-0.33	-0.31	-0.25	-0.27	-0.51	-0.55	-0.57	-0.53	-0.44	-0.56

Net Income	1,724	2,018	2,385	2,518	2,473	2,367	1,868	1,847	2,004	2,123	2,663	2,743	2,965	3,164	3,137	3,338	3,470	3,683	3,806	3,501
Change (%)		17.04	18.22	5.55	-1.76	-4.31	-21.06	-1.14	8.53	5.90	25.46	2.99	8.12	6.69	-0.84	6.41	3.95	6.15	3.33	-8.00
% of Revenue	13.12	14.60	17.33	17.90	17.63	16.82	12.53	11.72	12.02	11.90	14.38	14.30	14.85	15.04	14.41	14.72	14.59	14.89	14.51	13.20

Source: Capital IQ

Marksans Pharma Limited - Laporan Laba Rugi (TTM)

Laporan Laba Rugi (TTM)

Other Listings